Enasidenib Tablets is used for the treatment of patients with blood cell cancer (acute myeloid leukemia-AML).

Enasidenib is used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the IDH2 gene, determined by an FDA-approved IDH2 companion diagnostic test.

Enasidenib Tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Enasidenib Tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Enasidenib Tablets medicine cost price in India.

The order for Enasidenib Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Trade Name: Request you to fill the query form for more details.

Generic Name: Enasidenib Tablets

TARCEVA (Enasidenib Tablets

Enasidenib Tablets is available.

Get In Touch

Enasidenib Tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Enasidenib Tablets on prescription and Import License in Patient's Name only.

For overseas patients, Enasidenib Tablets can be made available in Send your enquiry to find Enasidenib Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Enasidenib Tablets.

Acute Leukemia: 5 Things to Know For More Details

Enasidenib Plus Azacitidine Significantly Improves Complete Remission, Overall Response in Patients With Newly Diagnosed AML With IDH2 Mutations For More Details